1. Home
  2. GOSS vs IVR Comparison

GOSS vs IVR Comparison

Compare GOSS & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.32

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Logo INVESCO MORTGAGE CAPITAL INC

IVR

INVESCO MORTGAGE CAPITAL INC

HOLD

Current Price

$8.76

Market Cap

633.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
IVR
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
633.2M
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
GOSS
IVR
Price
$2.32
$8.76
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$8.83
$8.25
AVG Volume (30 Days)
5.5M
2.9M
Earning Date
03-12-2026
01-29-2026
Dividend Yield
N/A
16.53%
EPS Growth
N/A
104.19
EPS
N/A
1.32
Revenue
$44,051,000.00
$119,840,000.00
Revenue This Year
N/A
$150.63
Revenue Next Year
$6.41
N/A
P/E Ratio
N/A
$6.60
Revenue Growth
N/A
51.01
52 Week Low
$0.76
$5.86
52 Week High
$3.87
$9.50

Technical Indicators

Market Signals
Indicator
GOSS
IVR
Relative Strength Index (RSI) 39.85 46.70
Support Level $2.24 $8.57
Resistance Level $2.41 $9.17
Average True Range (ATR) 0.22 0.22
MACD -0.00 -0.03
Stochastic Oscillator 21.85 26.98

Price Performance

Historical Comparison
GOSS
IVR

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

Share on Social Networks: